1. Introduction {#sec1-ijms-20-01485}
===============

Mesenchymal stem cells (MSCs) are a type of adult stem cells derived from the mesoderm. MSCs were first discovered by Friedenstein and his colleagues in mouse bone marrow cultures half a century ago \[[@B1-ijms-20-01485]\]. Later, the cells were isolated from a number of adult tissues, including adipose tissue \[[@B2-ijms-20-01485]\], pulp \[[@B3-ijms-20-01485]\], and postpartum discarded tissue, such as umbilical cord \[[@B4-ijms-20-01485],[@B5-ijms-20-01485],[@B6-ijms-20-01485]\], placenta \[[@B7-ijms-20-01485]\], amniotic membrane \[[@B8-ijms-20-01485]\], and cord blood \[[@B9-ijms-20-01485]\]. MSCs lack unique cell membrane surface markers, and can be identified by three biological characteristics: adherent properties, a series of cell-specific expression of cell surface markers, and multilineage differentiation potential \[[@B10-ijms-20-01485]\]. The rise in high-throughput sequencing technologies in the past few years has made it possible to understand MSCs at the molecular level, and further tap the potentials of MSCs.

Humans have owned dogs as companions for thousands of years. With improving living standards worldwide, dog health has improved, and the life span of dogs has increased. Improved dog health and longevity can be ascribed to advanced diagnostic and veterinary treatment procedures \[[@B11-ijms-20-01485],[@B12-ijms-20-01485],[@B13-ijms-20-01485]\]. In addition, dogs have become an ideal animal experimental model, because they have developed nervous and digestive systems \[[@B14-ijms-20-01485],[@B15-ijms-20-01485],[@B16-ijms-20-01485]\], as well as a number of physiological characteristics that are similar to humans \[[@B17-ijms-20-01485]\]. As a result, dogs are often used in drug development clinical trials \[[@B18-ijms-20-01485],[@B19-ijms-20-01485]\]. Current traditional medical treatments have a poor effect in curing numerous dog diseases and injuries, including nerve damage, kidney damage, hepatitis, and diabetes. Therefore, the scientists are constantly exploring new medical tools \[[@B14-ijms-20-01485],[@B20-ijms-20-01485],[@B21-ijms-20-01485],[@B22-ijms-20-01485],[@B23-ijms-20-01485]\]. The emergence of stem cell therapy brings new hope for the treatment of these diseases \[[@B24-ijms-20-01485],[@B25-ijms-20-01485]\]. The homing and low immunogenicity of MSC make them ideal seed cells for stem cell therapy \[[@B26-ijms-20-01485]\]. However, MSC application-based research has been mostly from human and murine sources, and there has been less research on dog MSCs. What remains unclear is whether dog MSCs have the same biological characteristics as other sources. In addition, previous studies have addressed two or three different sources of MSCs; however, this study was conducted to systematically compare the most common five different sources of MSCs. Therefore, accelerating the study of the biological characteristics of canine MSCs will provide a theoretical basis for the clinical selection and use of MSCs, and bring new hope for the veterinary field and translational medicine. MSCs not only have repair and therapeutic effects in viral and injurious diseases, but also have diagnostic and therapeutic effects in metabolic diseases, such as obesity and pregnancy-related diseases \[[@B27-ijms-20-01485],[@B28-ijms-20-01485],[@B29-ijms-20-01485]\]. The overall aim of this study was to investigate growth characteristics and the proliferative capacity of MSCs derived from adipose, bone marrow, umbilical cord, placenta, and amnion. Furthermore, adipogenic and osteogenic differentiation, as well as the transcriptome profile of MSCs was studied to provide baseline data on canine MSCs, which may be used in follow-up clinical cell therapies.

2. Results {#sec2-ijms-20-01485}
==========

2.1. Isolation and Primary Culture of Mesenchymal Stem Cells {#sec2dot1-ijms-20-01485}
------------------------------------------------------------

After 48 h of primary culture, a small number of adhered cells could be observed in all of the five types of cells. Initially, the cell morphologies were uneven, showing short spindles or polygons ([Figure 1](#ijms-20-01485-f001){ref-type="fig"}A--E). The cell-forming clones were scattered in the bottom of the dish. Adipose mesenchymal stem cells (AD-MSCs) reached 90% confluence on the fifth day, while the other cells reached confluence around the tenth day ([Figure 1](#ijms-20-01485-f001){ref-type="fig"}F--J).

The cell morphologies were subsequently fibrous or fusiform. After the passaging of the cells, the proliferation rate of the cells increased exponentially, and the cell morphologies were relatively uniform (i.e., they could be considered pure MSCs). Therefore, P3 cells were used in the subsequent experiments.

2.2. Growth Curve and Population Doubling Time of Mesenchymal Stem Cells {#sec2dot2-ijms-20-01485}
------------------------------------------------------------------------

As can be seen from [Figure 2](#ijms-20-01485-f002){ref-type="fig"}, the proliferation of MSCs was not significant at 1 to 2 days after passage. However, MSCs entered the logarithmic growth phase from the third to the sixth day and entered the plateau phase at the seventh day. According to the growth curve of P3 cells, the mean population doubling times of AD-MSCs, placenta mesenchymal stem cells (P-MSCs), bone marrow mesenchymal stem cells (BM-MSCs), umbilical cord mesenchymal stem cells (UC-MSCs), and amniotic mesenchymal stem cells (AM-MSCs) were 15.8 ± 0.318 h, 21.2 ± 0.629 h, 26.2 ± 0.242 h, 35 ± 0.588 h, and 41.9 ± 0.954 h, respectively. There were significant differences among the groups (*p* \< 0.01). The population doubling time (PDT) of AD-MSC was significantly lower than that of the other four types of MSCs, indicating that AD-MSC has the fastest cell growth rate and the strongest cell proliferative ability when cultivated in vitro.

2.3. Mesenchymal Stem Cell Immunofluorescence Results {#sec2dot3-ijms-20-01485}
-----------------------------------------------------

The immunofluorescence identification revealed that all five MSC types expressed CD44 ([Figure 3](#ijms-20-01485-f003){ref-type="fig"}A--E), but not CD34 ([Figure 3](#ijms-20-01485-f003){ref-type="fig"}F--J).

2.4. Adipogenic and Osteogenic Differentiation Results {#sec2dot4-ijms-20-01485}
------------------------------------------------------

After three days of osteogenic induction, the shapes of the cells changed from fibers to polygons and scales. Calcium nodules appeared in the AD-MSCs, P-MSCs, UC-MSCs, AM-MSCs, and B-MSCs after 5, 7, 8, and 9 days of induction, respectively. All five types of MSCs were stained with alizarin red on the tenth day of induction. All MSCs showed red mineralized deposits ([Figure 4](#ijms-20-01485-f004){ref-type="fig"}A--E).

After adipogenic differentiation, the changes in the five types of MSCs were similar, and the cells had gradually shortened and rounded from their original typical fibrous shape. Initially, there were more dead cells in the induced differentiation. However, after a later stage of cell differentiation they became stable.

Lipid droplets were observed in AD-MSCs and BM-MSCs after 8 and 12 days of induced differentiation, respectively After two weeks of induced differentiation, small scattered droplets were observed in UC-MSCs, AM-MSCs, and B-MSCs. After one more week of induction, the lipid droplets became larger and their number increased. Oil red O staining showed that the lipid droplets were stained red ([Figure 4](#ijms-20-01485-f004){ref-type="fig"}F--J). The above results indicate that AD-MSCs have the fastest growth rate of the tested cells in osteogenic and adipogenic differentiation.

2.5. Expression of Surface Marker Genes on Five Types of Mesenchymal Stem Cells in Dogs {#sec2dot5-ijms-20-01485}
---------------------------------------------------------------------------------------

In this research, the fragments per kilobase of exon model per million reads mapped (FPKM) values of the five types of MSCs (under the same experimental conditions) were considered as the final reference values. The results, as shown in [Table 1](#ijms-20-01485-t001){ref-type="table"}, indicate that canine MSCs not only express three surface markers---CD73, CD90, and CD105---as defined by the International Society for Cell Therapy (ISCT), but also express CD13, CD44, CD49a, CD54, CD140a, CD140b, and MHC I (FPKM \> 1), but not CD11a, CD11b, CD14, CD19, CD33,CD34, CD45, CD86, CD 146, CD 271, or MHC (FPKM \< 1). However, due to the lack of suitable antibodies, some of these genes have not been detected at the protein level.

2.6. Cluster Analysis of Differentially Expressed Genes {#sec2dot6-ijms-20-01485}
-------------------------------------------------------

This study investigated the changes in gene expression of the gene expression profile of five types of MSCs. The unsupervised hierarchical clustering of our complete RNA-Seq transcriptome data was performed to compare the expression pattern of differential expression genes in the five groups. The clustering heat map reveals that UC-MSC and AM-MSC, as well as BM-MSC and AD-MSC gene expression levels were similar, while P-MSC gene expression levels were significantly different from those the other four types (UC-MSC, AM-MSC, BM-MSC, and AD-MSC) ([Figure 5](#ijms-20-01485-f005){ref-type="fig"}).

2.7. Transcriptome Sequencing Analysis {#sec2dot7-ijms-20-01485}
--------------------------------------

The transcriptome sequencing results (see [Supplementary Material](#app1-ijms-20-01485){ref-type="app"}) showed that perinatal-derived MSCs (AM-MSCs, UC-MSCs, and P-MSCs) and body-derived MSCs (BM-MSCs and AD-MSCs) shared 94 up-regulated and 150 down-regulated genes, respectively. Typical differentially expressed genes are listed in [Table 2](#ijms-20-01485-t002){ref-type="table"}.

2.8. Validation of Transcriptome Results by Quantitative Reverse Transcriptase-PCR {#sec2dot8-ijms-20-01485}
----------------------------------------------------------------------------------

Differential and non-differentiated genes in each group were selected for qRT-PCR analysis to validate transcriptome data, and the results showed a consistent trend with Illumina sequencing data, indicating the reliability of comparative analysis of our transcriptome ([Figure 6](#ijms-20-01485-f006){ref-type="fig"}).

3. Discussion {#sec3-ijms-20-01485}
=============

Basic research on stem cells has made the development of novel biopharmaceuticals, cell therapy, regenerative medicine, and tissue engineering possible \[[@B5-ijms-20-01485]\]. Although pluripotent embryonic stem cells isolated from early embryos have the greatest potential, they face enormous technical challenges and ethical dilemmas \[[@B30-ijms-20-01485],[@B31-ijms-20-01485]\]. To circumvent technical and ethical challenges that are associated with embryonic stem cells, adult MSCs have become an attractive alternative in stem cell research, because of their ability for self-renewal and multi-differentiation. Compared with embryonic stem cells, MSCs have multiple sources and lower immunogenicity, and avoid ethical and moral controversy.

In recent years, it has been found that adipose-derived MSCs have outstanding growth performance and differentiation potential \[[@B32-ijms-20-01485]\], while MSCs derived from postpartum discarded tissues, such as the umbilical cord \[[@B4-ijms-20-01485]\], placenta, and amniotic membrane are readily accessible with low cellular immunogenicity, and can be acquired from multiple sources. Therefore, MSCs have become a hot area of research \[[@B5-ijms-20-01485],[@B33-ijms-20-01485]\]. Although a number of published reports on the biological characteristics of adipose-derived, umbilical cord, placenta, and amniotic membrane MSCs are available, the publications are mostly about human-derived MSCs \[[@B7-ijms-20-01485],[@B34-ijms-20-01485]\]. The fact is that these cells were derived from different individuals and cultured in the different growth conditions, which have different influences on the characteristics of MSCs. To avoid problems associated with MSCs from different individuals that are cultivated in different conditions, in this study we successfully isolated MSCs from five types of canine tissues, including fat (adipose tissue), bone marrow, umbilical cord, amniotic membrane, and placenta (AD-MSC, BM-MSC, UC-MSC, AM-MSC, and P-MSC, respectively) from the same dog. The biological characteristics and gene expression of the five types of MSCs were compared.

All the five types of MSCs in this study were fibrous adherent cells. Since there is controversy regarding the identification of MSCs in the international community, this study used a series of criteria developed by the International Society for Cell Therapy (ISCT) to identify the isolated cells \[[@B35-ijms-20-01485]\]. According to the immunofluorescence staining results, all the five types of MSCs expressed the hyaluronate receptor CD44, but did not express the hematopoietic stem cell marker CD34; in addition, all of MSCs were induced into adipocytes and osteoblasts. Therefore, cells isolated from these five types of tissues were identified as MSCs. A transcriptome profile has found that canine MSCs not only express CD73, CD90, and CD105, which is consistent with the internationally recognized characteristics of MSC surface protein expression \[[@B36-ijms-20-01485]\], but they also express CD13, CD44, CD49a, CD73, CD140a, and CD140b, which is in accordance with the surface markers of human-derived mesenchymal stem cells \[[@B10-ijms-20-01485],[@B37-ijms-20-01485],[@B38-ijms-20-01485]\]. In addition, our study found that canine MSCs express CD54 and MHCI surface markers, but do not express CD8, CD33, CD29 and MHCII surface markers, which is consistent with previous studies on canine MSC results \[[@B39-ijms-20-01485],[@B40-ijms-20-01485],[@B41-ijms-20-01485]\]. Interestingly, our study showed that canine MSCs did not express CD146 and CD271, in contrast to a report by Boxall et al. \[[@B42-ijms-20-01485]\], which showed that CD146 and CD271 could be produced by human bone marrow mesenchymal stem cells. BM-MSCs were used as the gold standard for the comparison of the biological characteristics of other MSCs \[[@B32-ijms-20-01485]\]. These controversial results may be ascribed to differences in the expression of MSC surface markers in different species. This study has shown that to a certain extent, there are differences in the growth performance and differentiation potential of MSCs from different tissue sources in vitro. According to the growth curve analysis, as the number of passages increased, both the growth rate and the number of MSC cells decreased, which is in line with those of previous reports \[[@B32-ijms-20-01485],[@B43-ijms-20-01485]\].

We compared MSCs from the same generation, but from five different sources, and found that AD-MSC cells had the highest proliferation activity in vitro. On average, the number doubled every day. Additionally, MSCs still sustained good activity after 15 passages. Our results are similar to those obtained by Keith A et al. \[[@B32-ijms-20-01485],[@B44-ijms-20-01485]\]. Our results showed that AD-MSC cells were the smallest volume among the five types of MSCs, implying that relatively more cells are needed by AD-MSCs to achieve saturation density in the proliferation process. Furthermore, the growth curve showed that AD-MSC cell density exceeded other MSCs, and was mainly associated with the high expression of AD-MSC in cell division-associated protein 8 (CDCA8) and cyclin B2 (CCNB2) \[[@B9-ijms-20-01485]\]. Additionally, the expression of CDCA8 and CCNB2 in AD-MSC was higher than that of MSCs from other sources, but whether this may be the reason for the rapid proliferation of AD-MSC remains to be further explored. In addition to the ability of proliferation, differentiation is another important feature of MSCs. Differentiation is characterized by dramatic changes in the size, morphology, membrane potential, and the metabolic activity of cells \[[@B45-ijms-20-01485]\].The results of this experiment showed that the five types of MSCs can be differentiated into adipocytes, with AD-MSC having a significant advantage for lipid droplets to form and increase in numbers. The results of osteogenic differentiation showed that AD-MSC, followed by P-MSC, needed the shortest amount of time to form calcium nodules. Moreover, all the five types of MSCs had a high rate calcium nodule formation.

Based on the results of transcriptome sequencing, the five types of MSCs were divided into two groups: body-derived MSCs (bone marrow and fat MSCs) and perinatal-derived MSCs (placenta, amnion, and umbilical cord MSCs). Analysis and comparison of differential gene expression between the two groups of MSCs indicated that different genes may be involved in different biological processes and signaling pathways. Differential gene analysis showed that 94 genes and 150 genes in body-derived MSCs were up-regulated and down-regulated, respectively, in comparison between the two groups. Typical genes with down-regulated expression were *APOE*, *CDKN1A*, and *THBS1*, and those with up-regulated expression included *TFPI2*, *DPT*, and *FBN1*. Liu et al. have demonstrated that apolipoprotein APOE can process and transport fatty acids to nerve cells to protect neurons \[[@B46-ijms-20-01485]\]. Overexpression of the cyclin-dependent kinase inhibitor 1A (CDKN1A) causes cell cycle arrest, thus inhibiting cell proliferation \[[@B47-ijms-20-01485]\].It has been proven that THBS1 plays a role in platelet aggregation and angiogenesis, while PHLDA1 has been shown to be involved in the anti-apoptotic process of IGF1 \[[@B48-ijms-20-01485]\]. DIO3 regulates the circulating fetal thyroid hormone concentration during pregnancy, and thus prevents the premature exposure of fetal tissue to high levels of thyroid hormone \[[@B49-ijms-20-01485]\]. Due to the special function of the perinatal tissue to breed the fetus, DIO3 is highly expressed in the perinatal-source MSCs. The product of the H19 gene is a long non-coding RNA that acts as a tumor suppressor. The TGFBI protein is induced by transforming growth factor-β, and can inhibit cell adhesion \[[@B50-ijms-20-01485]\]. Mutation of this gene is associated with various types of corneal dystrophy. We observed that perinatal-derived MSCs, compared with body-derived MSCs, had lower proliferation activity and lower viscosity, which means they are more suitable for the treatment of nerve injury, thyroid hormone abnormalities, and so on. They also promote the speed of coagulation and angiogenesis, and are anti-apoptotic.

Among the up-regulated gene expression in body-derived MSCs, the *TFPI2* gene has been identified as a tumor suppressor gene in several types of cancers \[[@B51-ijms-20-01485]\]; DPT is a kind of extracellular matrix protein, which is considered to be the communication link between the surface and extracellular matrix environment of dermal fibroblasts. The control of TGF-beta bioavailability and the calibration of TGF-beta and BMP levels can adjust osteoblast maturation \[[@B52-ijms-20-01485]\], which suggests that the high osteogenic differentiation efficiency of body-derived MSCs in previous studies may be connected with their own high expression. S100A16 is a kind of calcium-binding protein that binds one calcium ion per monomer \[[@B53-ijms-20-01485]\]. It can promote the differentiation of adipocytes (in vitro). The overexpression in preadipocytes increases their proliferation, enhances adipogenesis, and reduces insulin-stimulated glucose uptake \[[@B54-ijms-20-01485]\]. This result is also consistent with previous adipogenic differentiation experiments. Intriguingly, body-derived MSCs have a remarkable ability for proliferation and adipogenic differentiation in vitro. These differences may provide a basis for the selection of MSCs in later clinical treatment, and make accurate treatment possible.

Although dogs are important animal models and domestic companion pets, only a few studies have documented the comparison of the biological criteria and transcriptome profile of canine MSCs. Comparative experiments showed that AD-MSC, P-MSC, AM-MSC, and UC-MSCs have similar biological properties with BM-MSCs, such as fibrous adherent growth, expression of cell surface marker CD44, non-expression of CD34, and osteogenesis and adipogenic differentiation. Therefore, we suggested that in follow-up clinical trials, postpartum tissue-derived MSCs offers a better choice than BM-MSCs. The transcriptome sequencing results showed that the gene expression pattern of P-MSCs is significantly different from that of the other four types of MSCs, which may be connected to their biological functions used to nourish the fetus. Furthermore, body-derived MSCs and perinatal-derived MCSs had their own particular characteristics, to achieve accuracy in the treatment in which stem cell therapy is applied.

4. Materials and Methods {#sec4-ijms-20-01485}
========================

4.1. Animals {#sec4dot1-ijms-20-01485}
------------

Dog adipose tissue, bone marrow, umbilical cord, placenta, and amniotic membrane were used in this experiment. All tissues were collected from the same adult Chinese rural dogs. All studies were approved by the Animal Ethics Committee of Foshan University, and were conducted in accordance with the ethical standards of the university. The project identification code is FSUeae2018006, and the approval date is 10 March, 2018.

4.2. Primary Culture of the Mesenchymal Stem Cell {#sec4dot2-ijms-20-01485}
-------------------------------------------------

For adipose mesenchymal stem cells (AD-MSCs), about 1 cm^3^; of adipose tissue was removed from the canine abdomen and washed with Phosphate Buffered Saline (PBS, Hyclon, Logan City, UT, USA) containing 5% Penicillin Streptomycin (Pen-Strep, Hyclon, America). The tissue was then minced and digested with 1 mg/mL of collagenase type I (Sigma, St.,Louis, MO, USA) at 37 °C for 1 h. After filtration through a 100-mesh cell strain, the filtrate was centrifuged for 5 min to collect AD-MSCs. The pellet was re-suspended into Dulbecco's Modified Eagle Media (DMEM, Hyclon, Logan City, UT, USA) complete medium (DMEM basic medium with 10% fetal bovine serum, 1% Pen-Strep, and 1% L-glutamine) and transferred into cell culture dishes (Corning, New York, NY, USA).

For the bone marrow mesenchymal stem cells (BM-MSC), the canine bone marrow fluid was extracted aseptically into an anticoagulant tube and diluted with PBS. The dilution was loaded onto Ficoll solution in a centrifugation tube. After 20 min of centrifugation, the white cloudy layer formed by the nucleated cells was carefully sucked out, washed with DMEM, and centrifuged for 5 min. At last, the cell pellet was resuspended in complete medium, and transferred into cell culture dishes.

For the umbilical cord mesenchymal stem cells (UC-MSC), umbilical cord tissue was carefully isolated from postpartum discarded tissue of a female canine. Then, the UC-MSCs were obtained as AD-MSCs, with a prolonged digestion time of collagenase up to 6 h.

To obtain amniotic mesenchymal stem cells (AM-MSCs) and placenta mesenchymal stem cells (P-MSCs), amniotic membrane and placental tissue were carefully isolated from postpartum discarded tissue and minced into small pieces. Then, the tissues were incubated in 0.25% trypsin for 30 min in a 37 °C water bath before FBS was applied to stop the digestion. Again, the primary AM-MSCs and P-MSCs were isolated as described above.

All five MSCs were cultivated in DMEM complete medium containing 10% fetal bovine serum (FBS, BI, Kibbutz Beit-Haemek, Israel), 1% L-glutamine (Hyclon, Logan City, UT, USA), and Pen-Strep. The medium was changed after 48 h of primary culture, and then non-adherent cells were washed away with PBS. The medium was changed every 3 days, until the cells were overgrown for passage. The growth of the cells was observed daily.

4.3. Cell Growth Curve Production {#sec4dot3-ijms-20-01485}
---------------------------------

P2, P5, and P8 of MSCs from 5 different sources were digested with trypsin and inoculated into 24-well plates at a concentration of 1 × 10^4^ cells/mL, and cultured at 37 °C in a 5% CO~2~ incubator. Three wells were randomly selected and counted after digestion "at the same time" each day for 8 days. The solution of the undigested wells was changed every 3 days. To create a growth curve, the number of days was plotted along on the abscissa and the number of cells on the ordinate.

4.4. Calculating Population Doubling Time {#sec4dot4-ijms-20-01485}
-----------------------------------------

To compare the MSC proliferation rates, the following formula was used to calculate the cell population doubling time (PDT). where *t* is the time for cell culture (unit: h), *N*~t~ is the number of cells after the culture (*t*), and *N*~0~ is the number of cells initially inoculated \[[@B55-ijms-20-01485]\].

4.5. Cellular Immunofluorescence Assay {#sec4dot5-ijms-20-01485}
--------------------------------------

The third-generation cells were inoculated on gelatin-coated 24-well culture plates. After adherence of the cells, the medium was discarded. Then the cells were washed twice with PBS containing 5% FBS, and fixed with 4% paraformaldehyde (Regal, Shanghai, China) at room temperature for 30 min. At last, immunofluorescence was performed to identify the expression of cell surface markers CD34 and CD44 (abcam, Cambridge, UK) \[[@B56-ijms-20-01485]\].

4.6. Adipogenic and Osteogenic Differentiation {#sec4dot6-ijms-20-01485}
----------------------------------------------

### 4.6.1. Induction of Adipogenesis {#sec4dot6dot1-ijms-20-01485}

P3 cells were seeded into 24-well plates at a density of 10^4^ cells/mL. The original medium was discarded when the cells reached 70% of confluence. DMEM adipogenic medium containing 10% fetal bovine serum, 1 μmol/L of dexamethasone, 10 μg/mL of insulin, and 200 μmol/mL of indomethacin (All from Cyagen, Suzhou, Jiangsu, China) was added into the cells. The fluid was replaced every 3 days. When the formation of lipid droplets in the cytoplasm was observed, the medium was carefully discarded. The cells were washed gently with PBS twice, fixed in 4% paraformaldehyde for 20 min, stained with oil red O (Solarbio, Beijing, China) for 30 min, and observed and photographed under a microscope. The time needed by each MSC to form a lipid droplet was recorded.

### 4.6.2. Induction of Osteogenesis {#sec4dot6dot2-ijms-20-01485}

P3 cells were seeded into 24-well plates at a density of 10^4^ cells/mL. The original culture medium was discarded the second day, and the DMEM osteoblast induction culture medium containing 10% fetal bovine serum, 0.1 μmol/L of dexamethasone, 10 mmol/L of sodium glycerophosphate, and 50 μmol/L of ascorbic acid (All from Cyagen, Suzhou, Jiangsu, China) was added for culture induction. The fluid was changed every 3 days. When bone calcification nodules were observed, they were identified with alizarin red (Solarbio, Beijing, China) staining. The time for each type of MSC to form calcium nodules was recorded.

4.7. Transcriptome Sequencing of Mesenchymal Stem Cells {#sec4dot7-ijms-20-01485}
-------------------------------------------------------

The third generation of MSC cells, which were isolated from the umbilical cord, amniotic membrane, placenta, adipose tissue, and bone marrow-derived MSCs, were cultivated under the same conditions. When they reached 80% of confluence, Trizol lysis was used to lyse the cells.

The total cellular RNA was extracted by the Universal RNA Extraction kit (TaKaRa, Japan) and done according to the procedure of El-Ashram et al. \[[@B57-ijms-20-01485]\]. After RNA quantization and purification evaluation \[[@B58-ijms-20-01485]\], the following procedures were performed:(1)The cDNA library for tanscriptome sequencing was prepared by the PCR method;(2)The TruSeq PE Clustering Kit of v3-c Bot-HS (Illumia) was used to cluster the index coded samples on the c-bot clustering generation system;(3)Purification of the raw data (raw readings) in FASTQ format was performed by an internal perl script, to obtain purified data of high quality for downstream analyses;(4)Reference genome and gene model annotation files were downloaded directly from the genome website (<https://www.ncbi.nlm.nih.gov/genome/85?genome_assembly_id=313739>, accessed on: 9 August 2016). The index of the reference genome was constructed by Hisat2 v2.0.4, which was also used to compare the paired-end purified reads and the reference genome;(5)For quantification of the expression level of genes, HTSeq v0.9.1 (Fabio Zanini, Stanford University, USA) was used to calculate the readings mapped to each gene. The FPKM of each gene was then calculated based on the length of the gene, and the readings localized to that gene were calculated too;(6)The DEGSeq R software package (1.20.0) (Bioconductor, Stanford University, USA) was used for differential expression analysis, and the Benjamini and Hochberg method was used for the adjustment of the *p* value. A corrected *p* value of 0.005 and log2 (fold change) was set to 1, as a threshold for a significant difference expression.

4.8. Quantitative Reverse Transcriptase-PCR Analysis {#sec4dot8-ijms-20-01485}
----------------------------------------------------

By random selection, eight genes that were overexpressed or repressed from each group, and without differential expression, were chosen for verification by quantitative RT-PCR, which was performed as follows: the total RNA was extracted using a MiniBEST Universal RNA Extraction kit (TaKaRa, Japan, Code No:9767), and reverse-transcribed employing a PrimeScript RT reagent kit (TaKaRa, Japan, Code No:RR047A); an SYBR green-based RT-PCR was conducted by using TB Green Premix Ex Taq II (TaKaRa, Japan, Code No:RR820A), according to the instructions made by the manufacturer. The primers were synthesized by Invitrogen, Shanghai, China. The qRT-PCR primer sequences are described in [Table 3](#ijms-20-01485-t003){ref-type="table"}. The results were expressed as fold changes \[[@B59-ijms-20-01485]\]. A correlation analysis was performed between the RNA-Seq and RT-PCR fold change results of the same RNA samples before pooling, using Graphpad Software (San Diego, CA, United States). Additionally, experiments were conducted in triplicate, and data are displayed as mean ± SD \[[@B60-ijms-20-01485]\].

5. Conclusions {#sec5-ijms-20-01485}
==============

We successfully isolated canine umbilical cord- adipose tissue-, amniotic membrane-, placenta-, and bone marrow-derived mesenchymal stem cells. All five cells showed fibrous adherent status, and expressed CD44 surface marker but not CD34. Five types of MSCs could differentiate into osteoblast and adipocyte. Among the five different sources of MSCs, AD-MSC had higher adipogenic differentiation efficiency than the other four types. Furthermore, AD-MSC had the best proliferative activity and the shortest population doubling time.

We are grateful to Xu Zhang, who help typed the manuscript and give the useful discussion.

Supplementary materials can be found at <https://www.mdpi.com/1422-0067/20/6/1485/s1>.

###### 

Click here for additional data file.

Conceptualization, B.-Y.W. and Z.-S.C.; Formal analysis, X.-S.Z. and H.-N.L.; Funding acquisition, B.-Y.W. and S.-F.C.; Investigation, X.-S.Z., D.-Z.L. and H.-N.L.; Methodology, X.-S.Z., S.E.-A., and Y.-S.B.; Project administration, B.-Y.W., Y.-S.B. and H.-Q.J.; Resources, B.-Y.W.; Software, S.-F.C. and C.-Y.L.; Writing---original draft, X.-S.Z. and D.-Z.L.; Writing---review and editing, S.E.-A.

This study is supported by Natural Science Foundation of Guangdong (Grant NO: 2017A030313171).

The authors declare no conflict of interest.

MSCs

Mesenchymal stem cells

AD-MSCs

Adipose Mesenchymal Stem Cells

AM-MSCs

Amniotic Mesenchymal Stem Cells

BM-MSCs

Bone Marrow Mesenchymal Stem Cells

P-MSCs

Placenta Mesenchymal Stem Cells

UC-MSCs

Umbilical Cord Mesenchymal Stem Cells

PDT

population doubling time

APOE

Apolipoprotein E

HSP90AA1

heat shock protein 90 alpha family class A member 1

IGFBP4

insulin like growth factor binding protein 4

THBS1

thrombospondin 1

PDGFRA

platelet derived growth factor receptor alpha
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![Dendrogram and unsupervised hierarchical clustering heat map (using Euclidean distance) of gene expression, based on the log ratio fragments per kilobase of exon model per million reads mapped (FPKM) data. Each column represents an experimental condition; each row represents a gene. For differentially expression genes, their log2 (RPKM) will be clustered. Red indicates up-regulation, and blue indicates down-regulation. The vertical distances on each branch of the dendrogram represent the degree of similarity between gene expression profiles of the five MSC groups.](ijms-20-01485-g005){#ijms-20-01485-f005}

![Validation of RNA-Seq data by employing qRT-PCR for the expression of Apolipoprotein E (APOE); heat shock protein 90, alpha family class A member 1 (HSP90AA1); insulin-like growth factor binding protein 4 (IGFBP4); thrombospondin 1(THBS1); and platelet-derived growth factor receptor alpha (PDGFRA). *X*-axis: gene name; *Y*-axis: log2 fold change in gene expression in each group (**A**--**K**).](ijms-20-01485-g006){#ijms-20-01485-f006}
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###### 

Test results of the expression of canine MSC surface marker genes.

  Surface Marker   Gene Symbol   Gene Name                                                Gene ID     Expression in MSC
  ---------------- ------------- -------------------------------------------------------- ----------- -------------------
  CD11a            ITGAL         integrin subunit alpha L                                 489905      \-
  CD11b            ITGAM         integrin subunit alpha M                                 489928      \-
  CD13             ANPEP         alanyl aminopeptidase, membrane                          403913      \+
  CD14             CD14          CD14 molecule                                            607076      \-
  CD19             CD19          CD19 molecule                                            607898      \-
  CD33             CD33          myeloid cell surface antigen CD33                        100686511   \-
  CD34             CD34          CD34 molecule                                            415130      \-
  CD44             CD44          CD44 molecule                                            403939      \+
  CD45             PTPRC         protein tyrosine phosphatase, receptor type C            490255      \-
  CD49a            ITGA1         integrin subunit alpha 1                                 489210      \+
  CD54             ICAM1         intercellular adhesion molecule 1                        403975      \+
  CD73             NT5E          NT5E 5′-nucleotidase ecto                                474984      \+
  CD86             CD86          CD86 molecule                                            403764      \-
  CD90             THY-1         Thy-1 cell surface antigen                               489365      \+
  CD105            ENG           endoglin                                                 609166      \+
  CD140a           PDGFRA        platelet derived growth factor receptor alpha            442860      \+
  CD140b           PDGFRB        platelet derived growth factor receptor beta             442985      \+
  CD146            MCAM          melanoma cell adhesion molecule                          489368      \-
  CD271            NGFR          nerve growth factor receptor                             491071      \-
  MHC I            DLA88         MHC class I DLA-88                                       474836      \+
  MHC II           DLA-DQA1      major histocompatibility complex, class II, DQ alpha 1   474861      \-

Note: "+"indicates that gene has expression level(FPKM ≥ 1); "-"indicates that gene has no expression level (FPKM \< 1).
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###### 

Differences in differentially expressed genes (FPKM) between body-derived MSCs and perinatal-derived MSCs.

  Gene ID                    Symbol    Gene Name                                                             Gene Expression in Body-Derived MSCs (FPKM)   Gene Expression in Perinatal-Derived MSCs (FPKM)                               
  -------------------------- --------- --------------------------------------------------------------------- --------------------------------------------- -------------------------------------------------- ------------- ------------- -------------
  **down-regulated genes**                                                                                                                                                                                                                
  476438                     APOE      apolipoprotein E                                                      19.48230703                                   173.6654375                                        1567.506632   7989.110095   546.5077788
  474890                     CDKN1A    cyclin dependent kinase inhibitor 1A                                  61.95423033                                   43.52563608                                        236.424318    1121.066431   218.6291872
  487486                     THBS1     thrombospondin 1                                                      119.3758949                                   125.0178298                                        1524.233918   888.0058028   1051.135618
  480221                     RPL17     ribosomal protein L17                                                 75.71858715                                   82.25616537                                        721.1519554   826.9961484   638.3271764
  475792                     ACTG2     actin, gamma 2, smooth muscle, enteric                                6.399918524                                   0.414750909                                        351.1864758   766.518074    137.3140666
  100856417                  RASL11A   RAS like family 11 member A                                           0.876201127                                   1.40855383                                         680.0949342   629.3313239   673.6109411
  611312                     PHLDA1    pleckstrin homology like domain family A member 1                     23.28421611                                   12.87378946                                        310.0875622   595.7103922   192.2748208
  612596                     DIO3      iodothyronine deiodinase 3                                            4.054952104                                   0                                                  136.8582098   427.3538336   243.7423875
  100271858                  H19       H19, imprinted maternally expressed transcript (non-protein coding)   0.161668492                                   0.681456125                                        881.4958725   379.2382548   87.40665754
  100855619                  IGFBP3    insulin like growth factor binding protein 3                          0.426966827                                   0.014979892                                        439.8998024   353.5566142   162.0637504
  478256                     FSIP1     fibrous sheath interacting protein 1                                  41.95676806                                   39.66236813                                        507.9665302   240.06563     353.193685
  481519                     TGFBI     transforming growth factor beta induced                               22.9651713                                    35.26254056                                        200.9835386   178.8766204   205.2200716
  **up-regulated genes**                                                                                                                                                                                                                  
  475230                     TFPI2     tissue factor pathway inhibitor 2                                     1898.736999                                   266.7345781                                        4.765569024   32.96191818   44.31133656
  490355                     DPT       dermatopontin                                                         309.4514262                                   236.9797415                                        27.20988994   21.23019758   57.24591462
  478293                     FBN1      fibrillin 1                                                           289.0483951                                   397.5158581                                        87.97115218   47.3419576    54.44982126
  609105                     PRRX1     paired related homeobox 1                                             277.7767982                                   277.8458835                                        62.8372572    35.17884243   52.27789448
  490458                     S100A16   S100 calcium binding protein A16                                      134.3591612                                   141.5546125                                        1.853236286   28.06769912   11.59700716
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###### 

Primer sequences used for qRT-PCR.

  -----------------------------------------------------------------------
  Gene Symbol   Product Length   Temperature   Primer Sequence
  ------------- ---------------- ------------- --------------------------
  APOE          163              59.49 °C      F: GGTGAAGATGGAGGAGCAGG\
                                               R: CTTAGAGGTGGGGATGGTGG

  COX1          198              58.93 °C      F: GGTCAGCCCGGTACTTTACT\
                                               R: TGGAGGAAGGAGTCAGAAGC

  HSP90B1       164              58.58 °C      F: GCAGTTTGGTGTCGGTTTCT\
                                               R: TAATTGTTGTTCCCCGTCCG

  HSP90A        194              58.95 °C      F: GTTCGGATGAGGAGGAGGAG\
                                               R: TGCCAAGTGATCTTCCCAGT

  IGFBP4        192              59.11 °C      F: CCGGAAAACAGGAGTGAAGC\
                                               R: CCAGAGACAGAGCCAGGAC

  PGS1          190              58.64 °C      F: CAGCCAGCAACCAATCACTA\
                                               R: CCTTTCCCCAGCATTCACAC

  PDGFRA        187              59.03 °C      F: ATCGAAGGCAGGCACATCTA\
                                               R: TGTACCACCCCATCATTGCT

  THBS1         160              59.09 °C      F: GCGCTCCTGTGATAGTCTCA\
                                               R: GATCACACCATCACCACACG
  -----------------------------------------------------------------------
